However, the tumor weight of mice in the P38B-treated groups was not reduced significantly compared with the control (dog IgG) group in CHO/dPDPN xenograft models (Fig. 4A), suggesting that CDC of P38B alone did not exhibit sufficient antitumor activity. Here, MAPK11 is linked to neoplasm.